- 专利标题: Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output
-
申请号: US17939067申请日: 2022-09-07
-
公开(公告)号: US12082930B2公开(公告)日: 2024-09-10
- 发明人: Peter Ajemba , Keith Nogueira , Jeffrey Nishida , Andy Y. Tsai
- 申请人: Medtronic MiniMed, Inc.
- 申请人地址: US CA Northridge
- 专利权人: MEDTRONIC MINIMED, INC.
- 当前专利权人: MEDTRONIC MINIMED, INC.
- 当前专利权人地址: US CA Northridge
- 代理机构: Weaver Austin Villeneuve & Sampson LLP
- 分案原申请号: US16117466 2018.08.30
- 主分类号: A61B5/1495
- IPC分类号: A61B5/1495 ; A61B5/00 ; A61B5/0205 ; A61B5/021 ; A61B5/024 ; A61B5/11 ; A61B5/145 ; A61B5/1455 ; A61B5/1468 ; A61B5/1486 ; G01N27/02 ; G06N5/022 ; G16H20/17 ; G16H40/40 ; G16H50/30 ; G16H50/70
摘要:
A continuous glucose monitoring system may utilize externally sourced information regarding the physiological state and ambient environment of its user for externally calibrating sensor glucose measurements. Externally sourced factory calibration information may be utilized, where the information is generated by comparing metrics obtained from the data used to generate the sensor's glucose sensing algorithm to similar data obtained from each batch of sensors to be used with the algorithm in the future. The output sensor glucose value of a glucose sensor may also be estimated by analytically optimizing input sensor signals to accurately correct for changes in sensitivity, run-in time, glucose current dips, and other variable sensor wear effects. Correction actors, fusion algorithms, EIS, and advanced ASICs may be used to implement the foregoing, thereby achieving the goal of improved accuracy and reliability without the need for blood-glucose calibration, and providing a calibration-free, or near calibration-free, sensor.
公开/授权文献
信息查询